price

NASDAQ · PRQR
ProQR Therapeutics N.V.
Healthcare · Biotechnology
$1.64
Up+$0.01 (+0.31%)
Updated Oct 4, 2026, 6:56 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 249.67M
- P/E ratio
- -5.37
- Dividend yield
- 0.00%
- 52-week range
- $1.35 – $2.46
- Volume
- 622.64K
- Avg. volume
- 502.75K
Price performance · PRQR
PRQR price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
PRQR closed at $1.64 after 19 trading sessions, down 20.24% for the selected period.
- Last close
- $1.64
- Period change
- -20.24%
- Period low
- $1.63
- Period high
- $2.05
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $1.65 | $1.665 | $1.62 | $1.635 | 622.64K |
| Oct 1, 2026 | $1.66 | $1.6861 | $1.55 | $1.63 | 1.97M |
| Sep 30, 2026 | $1.67 | $1.69 | $1.64 | $1.66 | 678.47K |
| Sep 29, 2026 | $1.66 | $1.70 | $1.63 | $1.65 | 382.27K |
| Sep 28, 2026 | $1.69 | $1.69 | $1.62 | $1.65 | 471.63K |
| Sep 25, 2026 | $1.72 | $1.72 | $1.63 | $1.65 | 584.82K |
| Sep 24, 2026 | $1.70 | $1.725 | $1.66 | $1.71 | 604.38K |
| Sep 23, 2026 | $1.89 | $1.89 | $1.69 | $1.70 | 1.14M |
| Sep 22, 2026 | $1.87 | $1.91 | $1.84 | $1.90 | 433.85K |
| Sep 21, 2026 | $1.86 | $1.8799 | $1.815 | $1.86 | 407.26K |
| Sep 18, 2026 | $1.89 | $1.89 | $1.83 | $1.83 | 570.09K |
| Sep 17, 2026 | $1.90 | $1.9199 | $1.87 | $1.89 | 432.95K |
| Sep 16, 2026 | $1.85 | $1.9017 | $1.79 | $1.86 | 741.89K |
| Sep 15, 2026 | $1.89 | $1.89 | $1.79 | $1.84 | 721.67K |
| Sep 14, 2026 | $1.88 | $1.88 | $1.8114 | $1.86 | 630.05K |
| Sep 11, 2026 | $1.97 | $1.98 | $1.85 | $1.86 | 581.23K |
| Sep 10, 2026 | $1.96 | $1.96 | $1.915 | $1.94 | 479.99K |
| Sep 9, 2026 | $2.05 | $2.125 | $1.97 | $1.99 | 958.27K |
| Sep 8, 2026 | $2.07 | $2.11 | $2.02 | $2.05 | 449.2K |
Latest PRQR news
The latest Smart Investors Daily articles mentioning PRQR.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

